NCT04294160 2025-12-24
A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer
Novartis
Phase 1 Terminated
Novartis
Institut National de la Santé Et de la Recherche Médicale, France
Centre Leon Berard
Immuneering Corporation